|
 |
|
Availability at any time, around the world; high reliability; identical safety standards - these are critical requirements that the process chain between suppliers and pharmaceutical companies must inevitably meet. 
|
|
 |
|
|
|
| BASF is expanding its existing range of highly interesting substituted tetrahydropyran derivatives. Recently, BASF has made 4 tetrahydropyranone accessible.
|
|
|
|
|
|
| Working together closely with the University of Graz, BASF managed to make enoate reductases (ERs), a group of special enzymes, accessible for industrial use.
|
|
|
Your opinion matters!
Do you like this newsletter? Can we improve it? Please let us know what you think in the Inside Life Sciences News online survey. 
|
|
|
|
|
|
BASF has established a new process for producing methanesulfonic acid (MSA) for pharmaceutical uses, under the brand name MSA 100.
|
|
|
|
|
|
|
Dr. Andreas Leitner (BASF) has just published a remarkable article in "sp2" regarding the Negishi cross-coupling reaction for commercial applications.
|
|
|
|
|
|
| In this feature of our newsletter we share answers to questions frequently asked of our scientists during technical presentations or BASF webinars. In this issue we focus on organozinc halides in organic synthesis - the topic of our latest webinar.
|
|
|
 |
|
|
|
|
The prevailing view of the pharmaceutical industry in the developed world is that it is highly regulated, adheres to stringent standards and consistently delivers high-quality medicines to patients.
|
|
|
|
|
|
|
A distinguished gathering of representatives of global companies, renowned Boron scientists and experts from BASF's own research and development team will gather for the Sixth International BASF Boron Conference at the BASF Conference Center in Ludwigshafen.
|
|
|
|
|
|
| BASF will showcase technology, expertise and resources that help pharmaceutical companies get drugs to market faster and more cost effectively at Informex 2010, February 16-19, at the Moscone Center, San Francisco, California.
|
|
|
|
|
|
|
Ongoing research and development projects depend on one thing above all: fast availability.
|
|
|
|
|
|
| In an expert paper on "BASF's ChiPros® chiral building blocks – the cornerstones of your API syntheses" recently published in "Chemistry Today", Dr. Andrea Simon and Dr. Ulrich Karl provide an overview of BASF's chiral products.
|
|
|
|
|
|
|
Read our new overview regarding recent precious metal prices.
|
|
|
|
|
|
New people in the Pharma team.
|
|
|
|
|
| Pharma meetings and events around the globe.
|
|
